Listed by the USPTO as LALONDE, ALEXANDRA ELIZABETH
Tech Center 3700 • Art Units: 3763 3783
This examiner grants 71% of resolved cases
LALONDE, ALEXANDRA ELIZABETH is assigned to tech center 3700 and art unit 3763. The record covers 396 resolved cases, with a 71.2% allowance rate and a median of 1238 days to allowance.
Interviews correspond to a 32.8% lift in the recorded allowance outcome. The principal companies are Cardinal Health Inc., Koninklijke Philips N.V., and Amgen Inc. The leading firms are Maschoff Brennan (OC)(BD), Blank Rome LLP, and Dragon Sun Law Firm, PC. Counsel may therefore give particular attention to interview preparation and follow-up.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18081480 | Acute Central Venous Catheter Symmetric Filler | Non-Final OA | Bard Access Systems, Inc. |
| 18600292 | SELF-GUIDING CATHETER WITH PROXIMITY SENSOR | Non-Final OA | Covidien LP |
| 18388112 | Sheath with Mechanism to Stop Bleeding Around Access Site | Final Rejection | Boston Scientific Scimed Inc. |
| 17479883 | PRESSURE RELEASE FOR MEDICAL DEVICES | Final Rejection | Boston Scientific Scimed, Inc. |
| 18271425 | LIGHT PROTECTIVE INFUSION SET DEVICES | Non-Final OA | CAREFUSION 303, INC. |
| 17519191 | ANTI-SNAGGING INFUSION SETS | Non-Final OA | CareFusion 303, Inc. |
| 18277136 | DIAPHRAGM FOR A BREAST PUMP AND A BREAST PUMP HAVING THE DIAPHRAGM | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18266828 | PUMP SYSTEM | Final Rejection | KONINKLIJKE PHILIPS N.V. |
| 18433843 | Device For Administration of a Therapeutic Agent Solution and Method Comprising Same | Non-Final OA | BAXTER HEALTHCARE SA |
| 18044496 | DYNAMIC ELECTROPORATION | Final Rejection | Cochlear Limited |
| 17392847 | DEVICES AND METHODS FOR TREATING A STRICTURE ALONG THE BILIARY AND/OR PANCREATIC TRACT | Final Rejection | NORTHWESTERN UNIVERSITY |
| 17277533 | PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE | Final Rejection | AMGEN INC. |
| 17036690 | DRUG DELIVERY DEVICE | Non-Final OA | AMGEN INC. |
| 18266907 | OVAL PLUNGER PISTON WITHO-RING PRESSURE EQUALIZING CHANNELS FOR IMPROVED LEAK PERFORMANCE | Final Rejection | Becton, Dickinson and Company |
| 18099541 | Systems and Methods for Adjusting the Length of Line Draw Lever Lock Components for Compatibility With Various Length Peripheral Intravenous Catheters (PIVC) | Final Rejection | Becton, Dickinson and Company |
| 18782551 | MEDICAMENT DELIVERY DEVICE HAVING AN ACTIVATING MECHANISM | Non-Final OA | Sanofi |
| 18534306 | DRIVE TRAIN FOR DIAL OF A TORSION-SPRING ASSISTED WIND-UP INJECTION DEVICE | Final Rejection | Sanofi |
| 18729946 | Feedback mechanism | Non-Final OA | SHL Medical AG |
| 18129159 | SUCTION INSTRUMENT AND METHOD FOR VIDEO-ASSISTED THORACOSCOPIC SURGERY | Final Rejection | Scanlan International, Inc. |
| 18702359 | OPHTHALMIC DEVICE | Non-Final OA | aVISI Ltd. |
| 18682352 | SINGLE-USE NEUROTOXIN FORMULATIONS AND PACKAGING | Non-Final OA | AEON Biopharma Sub Inc. |
| 18240171 | VACUUM DEFLATION STRUCTURE, VACUUM PUMP ASSEMBLY AND BREAST PUMP | Non-Final OA | Shenzhen TPH Technology Co., Ltd. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy71.2% of resolved applications examined by Alexandra Elizabeth Lalonde were allowed (396 resolved cases), compared with 60.3% across Art Unit 3763 over the last five years.
This examiner's interview lift is +32.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Alexandra Elizabeth Lalonde took 1,238 days on average from filing to allowance.
Alexandra Elizabeth Lalonde examines applications in Art Unit 3763 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
